Machine Learning at GSK with Kim Branson - #536
Analysis
This article from Practical AI provides a concise overview of how GSK is integrating machine learning and artificial intelligence into its pharmaceutical business. It highlights key areas such as drug discovery using genetics data, the development of a massive knowledge graph for scientific literature analysis, and the creation of an AI Hub to manage infrastructure. The article also mentions a cancer research collaboration with King's College, showcasing the application of ML/AI in understanding individualized patient needs. The focus is on practical applications and the scale of GSK's AI initiatives.
Key Takeaways
- •GSK is heavily investing in ML/AI for drug discovery and other pharmaceutical applications.
- •They are utilizing large-scale knowledge graphs and specialized AI infrastructure (AI Hub).
- •Collaboration with academic institutions like King's College is crucial for cancer research using ML/AI.
Reference
“The article doesn't contain a direct quote.”